Sanofi/X
Jun 17, 2025, 14:30
Sanofi Presented New Data in Patients with Chronic Rhinosinusitis with Nasal Polyps and Coexisting Asthma at EAACI 2025
Sanofi shared a post on X:
“At EAACI 2025, we’re presenting new late-breaking data from our phase 4 head-to-head study in patients with chronic rhinosinusitis with nasal polyps (CRSwNP) and coexisting asthma.
Find out more about the results.”
More posts featuriing Sanofi on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 5, 2025, 20:31
Jul 5, 2025, 20:15
Jul 5, 2025, 20:00
Jul 5, 2025, 19:18
Jul 5, 2025, 18:52
Jul 5, 2025, 18:38